Icon Advisers’s NeoGenomics NEO Stock Holding History

Icon Advisers’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-57,649	Closed	-$517K	–	408
2017 Q2	$517K	Sell	57,649 -100,000	-63%	-$794K	0.04%	334
2017 Q1	$1.24M	Buy	+157,649	New	+$1.28M	0.09%	255
2016 Q3	–	Sell	-100,000	Closed	-$804K	–	440
2016 Q2	$804K	Buy	+100,000	New	+$802K	0.05%	278

Other funds holding NEO

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Icon Advisers's NEO Position: Q3 2017 in Review

Icon Advisers sold out of NeoGenomics (NEO) in Q3 2017, closing a stake of 57,649 shares — an estimated $517K sold.

Icon Advisers first reported a position in NEO in Q2 2016 and held it in 3 quarters. The position peaked at $1.24M in Q1 2017. 139 funds tracked by Wall St. Rank hold NEO as of Q3 2017.

Icon Advisers reported no remaining NeoGenomics position as of Q3 2017 after selling out during the quarter.
Icon Advisers sold 57,649 NeoGenomics shares in Q3 2017, an estimated $517K.
Icon Advisers first reported a position in NeoGenomics in Q2 2016 and held it in 3 quarters.
Icon Advisers's NeoGenomics position peaked at $1.24M in Q1 2017.
139 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2017.

Based on Icon Advisers's 13F filing for Q3 2017, filed 8 Nov 2017.